营养缺乏和结核病的治疗:药物治疗和临床影响
Anca Ionela Fâcă1,2, Denisa Ioana Udeanu1,2, Andreea Letiția Arsene1,2
1Faculty of Pharmacy, Carol Davila University of Medicine and Pharmacy, 6, Traian Vuia Street, 020956 Bucharest, Romania.
Nutrients
|June 13, 2025
概括
结核病 (TB) 管理需要解决药物营养物相互作用的问题. 个性化的营养支持和协作护理对于改善结核病患者的治疗结果和患者预后至关重要.
科学领域:
- 传染性疾病 传染性疾病
- 营养科学 营养科学
- 药理学 药理学是指药理学的学科.
背景情况:
- 由Mycobacterium tuberculosis引起的结核病 (TB) 是全球主要的死亡原因,影响肺部和潜在的其他器官.
- 结核病的药理管理,特别是多药耐药结核病 (MDR-TB),涉及复杂的疗法,可能会对营养状况产生负面影响.
- 存在一个有害的循环,即营养不良加剧了结核病的结果,结核病感染进一步损害了营养状况,特别是在资源有限的环境中.
研究的目的:
- 审查营养,药物治疗和药物营养相互作用之间的关键相互作用,以管理结核病和MDR-TB.
- 突出这些相互作用对患者结果和治疗疗效的临床意义.
- 倡导结核病治疗的整体,个性化方法.
主要方法:
- 这项研究是一篇叙事性综述,综合了有关该主题的现有证据.
- 它研究了抗结核药物对营养水平的影响以及营养对结核病进展的影响.
- 它讨论了营养支持和个性化方案的重要性.
主要成果:
- 抗结核药物经常与必需维生素和微量营养素的缺乏有关,导致不良影响.
- 营养支持已经显示出增强免疫恢复,减少结核病相关疾病和改善治疗坚持的潜力.
- 药物与食品的相互作用是常见的,需要在患者管理中仔细考虑.
结论:
- 优化结核病和MDR-TB治疗需要一个全面的战略,将药物治疗与个性化营养干预相结合.
- 涉及医生,药剂师和营养学家的协作方法对于评估患者需求和定制治疗至关重要.
- 专注于药理和营养方面的个性化疗法可以显著改善患者的预后并降低死亡率.
更多相关视频
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
18.8K
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
1.8K
相关概念视频
Pulmonary Tuberculosis V
174
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
174
Pulmonary Tuberculosis I
227
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
227
Pulmonary Tuberculosis IV
134
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
134
Pulmonary Tuberculosis II
215
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
215
Pulmonary Tuberculosis III
316
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
316
Pneumonia IV: Management
313
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
313
